EV/EBITDA
-1.78
-0.02-1.14%
27 min ago
Summary
- As of March 12, 2025, ALLO EV/EBITDA is -1.78, with a fall of -0.02 (-1.14%) during the most recent trading day.
- Over the past year, ALLO EV/EBITDA has increased by +1.07 (+37.54%).
- ALLO EV/EBITDA is now -43.55% below its all-time high of -1.24.
Performance
ALLO EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
ALLO EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -1.1% | +1.4% | +1.5% |
| 1 m1 month | -43.5% | +44.1% | +49.3% |
| 3 m3 months | -1.7% | +1.8% | +2.0% |
| 6 m6 months | +2.7% | -1.1% | -22.3% |
| ytdytd | +1.1% | -0.9% | -1.0% |
| 1 y1 year | +37.5% | -45.6% | -58.7% |
| 5 y5 years | +86.0% | -81.4% | -90.2% |
ALLO EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -43.5% | -2.46 | +27.6% | |
| 3 m | 3-month | -1.24 | -43.5% | -2.46 | +27.6% |
| 6 m | 6-month | -1.24 | -43.5% | -2.74 | +35.0% |
| 1 y | 1-year | -1.24 | -43.5% | -2.95 | +39.7% |
| 3 y | 3-year | -1.24 | -43.5% | -11.19 | +84.1% |
| 5 y | 5-year | -1.24 | -43.5% | -30.84 | +94.2% |
| alltime | all time | -1.24 | -43.5% | -30.84 | +94.2% |
Allogene Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -1.78(-1.1%) |
| 2024 | -1.80(-3.2%) |
| 2023 | -1.86(-37.2%) |
| 2022 | -2.96(-75.2%) |
| Date | Value |
|---|---|
| 2021 | -11.95(-12.3%) |
| 2020 | -13.62(-13.6%) |
| 2019 | -15.77(+1.5%) |
| 2018 | -15.53 |
FAQ
- What is Allogene Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Allogene Therapeutics?
- What is ALLO EV/EBITDA year-to-date change?
- What is Allogene Therapeutics EV/EBITDA year-on-year change?
What is Allogene Therapeutics EV/EBITDA?
The current EV/EBITDA of ALLO is -1.78
What is the all time high EV/EBITDA for Allogene Therapeutics?
Allogene Therapeutics all-time high EV/EBITDA is -1.24
What is ALLO EV/EBITDA year-to-date change?
Allogene Therapeutics EV/EBITDA has changed by +0.02 (+1.11%) since the beginning of the year
What is Allogene Therapeutics EV/EBITDA year-on-year change?
Over the past year, ALLO EV/EBITDA has changed by +1.07 (+37.54%)